Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 11045 results:
Συντάκτης [ Τίτλος(Asc)] Τύπος Έτος
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
Prapas, S. N., Panagiotopoulos I. A., Pentchev D. N., Ayyad M. A. Salama, Protogeros D. A., Kotsis V. N., et al. (2009).  Aorta no-touch off-pump coronary artery revascularization in octogenarians: 5 years' experience.. Heart Surg Forum. 12(6), E349-53.
Agorastos, A., Haasen C., & Huber C. G. (2012).  Anxiety disorders through a transcultural perspective: implications for migrants.. Psychopathology. 45(2), 67-77.
Papachrysos, N., Hytiroglou P., Papalavrentios L., Sinakos E., Kouvelis I., & Akriviadis E. (2015).  Antiviral therapy leads to histological improvement of HBeAg-negative chronic hepatitis B patients.. Ann Gastroenterol. 28(3), 374-378.
Melidou, A., Kyriazopoulou V., Diza E., Alexiou S., & Pierroutsakos Y. (2009).  Antiviral resistance of influenza A (H3N2) strains isolated in northern Greece between 2004 and 2007.. Euro Surveill. 14(4), 
Zampros, I., Praidou A., Brazitikos P., Ekonomidis P., & Androudi S. (2012).  Antivascular endothelial growth factor agents for neovascular age-related macular degeneration.. J Ophthalmol. 2012, 319728.
Mitsiades, C. S., McMillin D., Kotoula V., Poulaki V., McMullan C., Negri J., et al. (2006).  Antitumor effects of the proteasome inhibitor bortezomib in medullary and anaplastic thyroid carcinoma cells in vitro.. J Clin Endocrinol Metab. 91(10), 4013-21.
Ntusi, N. A. B., Francis J. M., Sever E., Liu A., Piechnik S. K., Ferreira V. M., et al. (2018).  Anti-TNF modulation reduces myocardial inflammation and improves cardiovascular function in systemic rheumatic diseases.. Int J Cardiol. 270, 253-259.
Athyros, V. G., Kakafika A. I., Tziomalos K., Karagiannis A., & Mikhailidis D. P. (2008).  Antisense technology for the prevention or the treatment of cardiovascular disease: the next blockbuster?. Expert Opin Investig Drugs. 17(7), 969-72.
Tsachouridou, O., Skoura L., Zebekakis P., Margariti A., Georgiou A., Bougiouklis D., et al. (2016).  Antiretroviral naive and treated patients: Discrepancies of B cell subsets during the natural course of human immunodeficiency virus type 1 infection.. World J Virol. 5(4), 155-160.
Papaioannidou, P., & Kasviki P. (2018).  Antipsychotics use in the community of Thessaloniki, Greece. Vojnosanitetski pregledMilitary Medical and Pharmaceutical Journal of Serbia. 75(5), 468 - 472.
Papaioannidou, P., Kasviki P., & Moschopoulos N. (2016).  Antipsychotic Prescribing in a Tertiary Hospital Under the Financial Crisis in Greece. Pharmacoepidemiol Drug Safety. 25(S3), 668.
Siafis, S., Deste G., Ceraso A., Mussoni C., Vita A., Hasanagic S., et al. (2019).  Antipsychotic drugs barbiturates or benzodiazepines used as active placebos for schizophrenia: a systematic review and meta-analysis.. Psychol Med. 1-12.
Chatzimoschou, A., Simitsopoulou M., Antachopoulos C., Walsh T. J., & Roilides E. (2015).  Antipseudomonal agents exhibit differential pharmacodynamic interactions with human polymorphonuclear leukocytes against established biofilms of Pseudomonas aeruginosa.. Antimicrob Agents Chemother. 59(4), 2198-205.
Gkaliagkousi, E., Gavriilaki E., & Douma S. (2015).  Antiplatelet treatment in essential hypertension: where do we stand?. Curr Hypertens Rep. 17(4), 536.
Moschos, M. M., Moustafa G. A., Papakonstantinou V. D., Tsatsos M., Laios K., & Antonopoulou S. (2017).  Anti-platelet effects of anti-glaucomatous eye drops: an in vitro study on human platelets.. Drug Des Devel Ther. 11, 1267-1272.
Tsounapi, P., Saito M., Dimitriadis F., Koukos S., Shimizu S., Satoh K., et al. (2012).  Antioxidant treatment with edaravone or taurine ameliorates diabetes-induced testicular dysfunction in the rat.. Mol Cell Biochem. 369(1-2), 195-204.
Tsounapi, P., Honda M., Dimitriadis F., Shimizu S., Shiomi T., Hikita K., et al. (2018).  Antioxidant treatment ameliorates diabetes-induced dysfunction of the vas deferens in a rat model.. Andrologia. 50(1), 
Liakopoulos, V., Roumeliotis S., Bozikas A., Eleftheriadis T., & Dounousi E. (2019).  Antioxidant Supplementation in Renal Replacement Therapy Patients: Is There Evidence?. Oxid Med Cell Longev. 2019, 9109473.
Polyzos, S. A., Goulis D. G., Giouleme O., Germanidis G. S., & Goulas A. (2022).  Anti-obesity Medications for the Management of Nonalcoholic Fatty Liver Disease.. Curr Obes Rep.
Ioannidis, P., Papadopoulos G., Koufou E., Parissis D., & Karacostas D. (2015).  Anti-NMDA receptor encephalitis possibly triggered by measles virus.. Acta Neurol Belg. 115(4), 801-2.
Lekakis, J., Dimopoulos M., Nanas J., Prassopoulos V., Agapitos N., Alexopoulos G., et al. (1997).  Antimyosin scintigraphy for detection of cardiac amyloidosis.. Am J Cardiol. 80(7), 963-5.
Poulas, K., Koutsouraki E., Kordas G., Kokla A., & Tzartos S. J. (2012).  Anti-MuSK- and anti-AChR-positive myasthenia gravis induced by d-penicillamine.. J Neuroimmunol. 250(1-2), 94-8.
Apostolidis, A. (2015).  Antimuscarinics in the Treatment of OAB: Is there a First-Line and a Second-Line Choice?. Curr Drug Targets. 16(11), 1187-97.
Piouka, A., Farmakiotis D., Katsikis I., Macut D., Gerou S., & Panidis D. (2009).  Anti-Mullerian hormone levels reflect severity of PCOS but are negatively influenced by obesity: relationship with increased luteinizing hormone levels.. Am J Physiol Endocrinol Metab. 296(2), E238-43.
Tolikas, A., Tsakos E., Gerou S., Prapas Y., & Loufopoulos A. (2011).  Anti-Mullerian Hormone (AMH) levels in serum and follicular fluid as predictors of ovarian response in stimulated (IVF and ICSI) cycles.. Hum Fertil (Camb). 14(4), 246-53.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.

           

Σύνδεσμοι

 

Το πανεπιστήμιο

 
 

Προσωπικό & Φοιτητές